Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 13/20 | 0.34 |
| ▸ | FEN1 | P39748 | 13/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.30 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356578 | 0.98 | ALOX5AP (0.35) | ALOX5APFEN1DGAT1RPS6KA3ESR2 | |
| SCHEMBL17359236 | 0.94 | ALOX5AP (0.33) | ALOX5APFEN1RPS6KA3 | |
| SCHEMBL17359251 | 0.88 | ALOX5AP (0.32) | ALOX5APFEN1 | |
| SCHEMBL13111383 | 0.88 | DGAT1 (0.36) | ALOX5APFEN1DGAT1ESR2 | |
| SCHEMBL172422 | 0.87 | ESR2 (0.38) | ALOX5APFEN1RPS6KA3ESR2NOTUM | |
| SCHEMBL12437063 | 0.87 | ESR2 (0.38) | ALOX5APFEN1RPS6KA3ESR2NOTUM | |
| SCHEMBL19754822 | 0.87 | ESR2 (0.38) | ALOX5APFEN1RPS6KA3ESR2NOTUM | |
| SCHEMBL17359301 | 0.85 | ALOX5AP (0.31) | ALOX5APFEN1 | |
| SCHEMBL17359246 | 0.84 | — | — | |
| SCHEMBL19176397 | 0.84 | FEN1 (0.46) | ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9527870-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20150368272-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368272-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | YBX3, OCIAD1, PIEZO1 | ALOX5AP 1818/4885FEN1 1419/4885DGAT1 2087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.